-
Silicon Valley's next risky self-optimization craze is unproven peptides
FDA's war on public health is about to end. This includes its aggressive suppression of psychedelics, peptides, stem cells, raw milk, hyperbaric therapies, chelating compounds, ivermectin, hydroxychloroquine, vitamins, clean foods, sunshine, exercise, nutraceuticals and anything...
– Robert F. Kennedy Jr October 25, 20242026-01-08
-
Life Sciences AI and Compliance: Trust But Rigorously Verify
Artificial intelligence (AI) continues to upend how businesses operate, and the life sciences field is no exception. Generative AI provides life sciences companies the ability to identify and learn from patterns in large data sets.
2025-09-18
-
Arc Institute Launches Virtual Cell Challenge to Accelerate AI Model Development
The open benchmark competition will evaluate the ability of virtual cell models to generalize to new cell contexts for therapeutic applications
Credit: Just_Super/Getty Images2025-09-18
-
Top 10 Contract Development and Manufacturing Organizations 2025
While biologics are expected to drive CDMO growth through 2033, foreign exchange rates and tariffs are looming challenges
2025-09-18
-
Industry Leaders: Women in Bioprocessing
We spotlights some of the remarkable women who are breaking barriers, setting standards, and driving innovation in this space.
2025-09-16
-
In a First, Brain-Wide Activity Mapped During Decision-Making
Outline of a mouse brain showing 75,000 analyzed neurons, each dot is linearly scaled according to the raw average firing rate of that neuron up to a maximum size. [Dan Birman, International Brain Laboratory]
2025-09-16
-
The Top 25 Digital Health Executives of 2025 | The Healthcare Technology Report.
2025-09-16
